Viewing StudyNCT00087698



Ignite Creation Date: 2024-05-05 @ 11:34 AM
Last Modification Date: 2024-10-26 @ 9:10 AM
Study NCT ID: NCT00087698
Status: COMPLETED
Last Update Posted: 2009-05-12
First Post: 2004-07-12

Brief Title: Phase II Trial of Neo-Adjuvant Pemetrexed Plus Cisplatin Followed by Surgery and Radiation for Pleural Mesothelioma
Sponsor: Eli Lilly and Company
Organization: Eli Lilly and Company

Key Dates - Follows AllAPIJSON File Order

Start Date: 2003-09
Start Date Type: None
Primary Completion Date: 2008-02
Primary Completion Date Type: ACTUAL
Completion Date: 2008-02
Completion Date Type: ACTUAL
First Submit Date: 2004-07-12
First Submit QC Date: July 15 2004
Study First Post Date: 2004-07-16
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: 2009-03-17
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2009-05-01
Last Update Post Date: 2009-05-12
Last Update Post Date Type: ESTIMATED